| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 7 | +14.29% | +24.13% | -0.29% | +24.42% | +2.34% | — |
| 14d | 7 | +28.57% | +35.02% | -0.88% | +54.11% | +54.34% | — |
| 30d | 7 | +20.00% | +46.85% | -1.74% | +49.27% | +65.39% | — |
| 60d | 7(2 pending) | +0.00% | +58.87% | +3.21% | +55.65% | +36.29% | — |
| 90d | 7(2 pending) | +0.00% | +142.37% | +5.04% | +103.14% | +24.79% | — |
| 180d | 7(4 pending) | +0.00% | +140.67% | +11.38% | +129.29% | +69.47% | — |
| 1y | 7(4 pending) | +33.33% | +147.55% | +16.97% | +130.59% | +210.18% | — |
| 2y | 7(6 pending) | +0.00% | +1014.54% | +34.61% | +979.94% | +979.94% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| QURE UNIQURE N.V. | SALE Chief Medical Officer | 10,000 | — | — | 50,500 | Jun 30, 2026 | Jul 2, 2026 ↗ | View → |
| QURE UNIQURE N.V. | SALE10b5-1 10b5-1 plan | 10,000 | $46.46 | $464.6K | 168,235 | Jun 30, 2026 | Jul 2, 2026 ↗ | View → |
| QURE UNIQURE N.V. | SALE10b5-1 10b5-1 plan | 20,000 | $46.40 | $928.0K | 148,235 | Jun 30, 2026 | Jul 2, 2026 ↗ | View → |
| QURE UNIQURE N.V. | PURCHASE Chief Medical Officer | 10,000 | $5.59 | $55.9K | 178,235 | Jun 30, 2026 | Jul 2, 2026 ↗ | View → |
| QURE UNIQURE N.V. | SALE Chief Medical Officer | 1,434 | $46.86 | $67.2K | 168,235 | Jun 26, 2026 | Jun 30, 2026 ↗ | View → |
| QURE UNIQURE N.V. | SALE10b5-1 10b5-1 plan | 20,000 | $25.00 | $500.0K | 169,669 | May 8, 2026 | May 12, 2026 ↗ | View → |
| QURE UNIQURE N.V. | SALE10b5-1 10b5-1 plan | 25,000 | $25.10 | $627.5K | 189,669 | May 8, 2026 | May 12, 2026 ↗ | View → |
| QURE UNIQURE N.V. | SALE Chief Medical Officer | 25,000 | — | — | 60,500 | May 8, 2026 | May 12, 2026 ↗ | View → |
| QURE UNIQURE N.V. | PURCHASE Chief Medical Officer | 25,000 | $5.59 | $139.8K | 214,669 | May 8, 2026 | May 12, 2026 ↗ | View → |
| QURE UNIQURE N.V. | PURCHASEGRANT Stock grant | 41,700 | — | — | 190,477 | Mar 4, 2026 | Mar 6, 2026 ↗ | View → |
| QURE UNIQURE N.V. | PURCHASEGRANT Stock grant | 67,200 | — | — | 67,200 | Mar 4, 2026 | Mar 6, 2026 ↗ | View → |
| QURE UNIQURE N.V. | SALE Chief Medical Officer | 808 | $9.06 | $7.3K | 189,669 | Mar 4, 2026 | Mar 6, 2026 ↗ | View → |
| QURE UNIQURE N.V. | SALE Chief Medical Officer | 1,660 | $9.95 | $16.5K | 148,777 | Mar 2, 2026 | Mar 4, 2026 ↗ | View → |
| QURE UNIQURE N.V. | SALE Chief Medical Officer | 1,466 | $13.92 | $20.4K | 150,437 | Jun 27, 2025 | Jul 1, 2025 ↗ | View → |
| QURE UNIQURE N.V. | SALE Chief Medical Officer | 1,350 | $10.29 | $13.9K | 151,903 | Mar 4, 2025 | Mar 5, 2025 ↗ | View → |
| QURE UNIQURE N.V. | PURCHASEGRANT Stock grant | 66,000 | — | — | 66,000 | Mar 3, 2025 | Mar 5, 2025 ↗ | View → |
| QURE UNIQURE N.V. | PURCHASEGRANT Stock grant | 38,000 | — | — | 153,253 | Mar 3, 2025 | Mar 5, 2025 ↗ | View → |
| QURE UNIQURE N.V. | SALE Chief Medical Officer | 1,447 | $4.36 | $6.3K | 115,253 | Jun 26, 2024 | Jun 28, 2024 ↗ | View → |
| QURE UNIQURE N.V. | PURCHASEGRANT Stock grant | 85,500 | — | — | 85,500 | Mar 1, 2024 | Mar 5, 2024 ↗ | View → |
| QURE UNIQURE N.V. | PURCHASEGRANT Stock grant | 49,500 | — | — | 116,700 | Mar 1, 2024 | Mar 5, 2024 ↗ | View → |